Panuveitis Presumed Secondary to Ibrutinib Therapy

Ophthalmic Surg Lasers Imaging Retina. 2021 Mar;52(3):160-164. doi: 10.3928/23258160-20210302-08. Epub 2021 Mar 1.


Although a small number of cases of secondary uveitis have been documented in the setting of ibrutinib therapy, panuveitis has not previously been described with this medication. The authors describe a presumed case of panuveitis in a patient on ibrutinib for chronic lymphocytic leukemia. The purpose of this report is to document a case of asymmetric, bilateral panuveitis in the setting of ibrutinib use. Panuveitis may develop in the setting of ibrutinib use, and local steroid therapy can be successfully used for treatment without cessation of systemic cancer therapy. [Ophthalmic Surg Lasers Imaging Retina. 2021;52:160-164.].

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Humans
  • Panuveitis* / chemically induced
  • Panuveitis* / diagnosis
  • Panuveitis* / drug therapy
  • Piperidines
  • Uveitis*


  • Piperidines
  • ibrutinib
  • Adenine